A clinical ly relevant but not statistically significant reduction in triglycerides was found .
No impact on HDL-C levels was found .
Patients ' adherence to pharmacotherapeutic regimens and quality of life were considered possibly not sensitive and possibly sensitive to pharmacist interventions , respectively .
Total cholesterol is sensitive to pharmacist interventions , while LDL-C and triglyceride levels are possibly sensitive to those interventions .
BACKGROUND Hyperlipidemia increases the risk of cardiovascular diseases , and control is pivotal for preventing disease complications .
Multidisciplinary interventions , including those performed by pharmacists , are important for improving patients ' outcomes .
OBJECTIVE To quantify the impact of pharmacist interventions in enhancing patients ' outcomes .
Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong.
A prospect i ve controlled study on the benefits of pharmacists ' individualized counseling on drug compliance , cholesterol concentration reduction , attainment of National Cholesterol Education Program ( NCEP ) Adult Treatment Panel III ( ATP III ) low-density lipoprotein cholesterol ( LDL-C ) goals , and patient satisfaction was carried out in a private community hospital in Hong Kong . All patients who were newly prescribed with lipid-lowering drugs for primary prevention were included . The patients in the individualized counseling group received " intense " counseling and follow-up of cholesterol concentration by a pharmacist for 3 months . The control group received routine counseling .  Fifty patients completed the study ( 26 in the individualized group , 24 in the control group ) .  Compliance was assessed , and those patients who achieved 75 % compliance were defined as compliers . In the individualized group , 76.9 % were compliers compared with 41.7 % in the control group ( p < 0.01 ) . The individualized group achieved 28.3 % , 27.7 % , and 26.1 % reduction in total cholesterol , LDL-C , and triglycerides , respectively , compared with 15.3 % , 16.3 % , and 10.6 % in the control group ( p < 0.05 for all ) . Also in the individualized group , 80.8 % achieved the ATP III LDL-C goals compared to 58.3 % in the control group ( p < 0.05 ) . Of patients in the individualized group , 85 % felt that the pharmacist counseling service could improve their disease management . The study demonstrated that pharmacists ' individualized counseling , together with the assessment of  cholesterol concentrations , had positive impacts on the management of hyperlipidemia , including improved drug compliance , better treatment endpoints , and patient satisfaction
A clinical ly relevant but not statistically significant reduction in triglycerides was found .
No impact on HDL-C levels was found .
Patients ' adherence to pharmacotherapeutic regimens and quality of life were considered possibly not sensitive and possibly sensitive to pharmacist interventions , respectively .
Total cholesterol is sensitive to pharmacist interventions , while LDL-C and triglyceride levels are possibly sensitive to those interventions .
BACKGROUND Hyperlipidemia increases the risk of cardiovascular diseases , and control is pivotal for preventing disease complications .
Multidisciplinary interventions , including those performed by pharmacists , are important for improving patients ' outcomes .
OBJECTIVE To quantify the impact of pharmacist interventions in enhancing patients ' outcomes .